Microdevice

COMBINATION_PRODUCT4 trials

Conditions

Anaplastic Astrocytoma of BrainAnaplastic OligodendrogliomaAstrocytomaFallopian Tube CancerFallopian Tube Cancer Stage IIIFallopian Tube Cancer Stage IVGlioblastomaGrade II Glioma

Early Phase 1

Implantable Microdevice In Primary Brain Tumors

RecruitingNCT04135807

Oliver JonasAnaplastic Astrocytoma of Brain, Anaplastic Oligodendroglioma, Astrocytoma +5

Start: 2020-03-03End: 2028-06-01Target: 12Updated: 2025-07-23

Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

Enrolling by invitationNCT06782399

Oliver JonasSquamous Cell Carcinoma, Squamous Cell Carcinoma of the Skin

Start: 2025-10-01End: 2028-07-01Target: 25Updated: 2026-05-18

Phase 1

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

Enrolling by invitationNCT04399876

Brigham and Women's HospitalProstate Cancer, Radical Prostatectomy

Start: 2020-06-22End: 2027-11-01Target: 35Updated: 2026-05-18

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

RecruitingNCT04701645

Brigham and Women's HospitalFallopian Tube Cancer, Fallopian Tube Cancer Stage III, Fallopian Tube Cancer Stage IV +4

Start: 2022-11-01End: 2027-06-30Target: 20Updated: 2026-05-18

Cancer Research2025-03-11

Novel Intraprostatic MR-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate Cancer

The Journal of Urology2024-09-301 citations

Abstract A011: An implantable microdevice to interrogate responses to therapy in ovarian cancer

Cancer Research2024-03-04

Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas

Science Translational Medicine2023-09-0617 citations

Microdevice

Sponsors

Conditions

Early Phase 1

Phase 1

Related Papers